Caplin Point Laboratories Limited
Caplin Point Laboratories Ltd is engaged in the manufacturing and sourcing of APIs, finished formulations, R&D, clinical research with presence in Latin America, Africa, USA and other nations.
What Caplin files
- Others44
- Investor Meet25
- Updates14
- Important14
- Board Meeting7
- Dividend/Bonus5
Caplin Point has declared an interim dividend of ₹4.00 (200%) per equity share (face value ₹2) for FY26. May 30, 2026, has been set as the record date. Shareholders holding shares on this date will be eligible to receive this interim dividend payout. This is a key event for investors...
Caplin Point Laboratories Limited has informed the Exchange that Board of Directors at its meeting held on May 14, 2026, declared Interim Dividend of Rs. 4 per equity share.
Caplin Point Laboratories Limited has informed the Exchange that Record date for the purpose of Dividend is 12-Sep-2025.
Caplin Point Laboratories Limited has informed the Exchange that Board of Directors at its meeting held on August 07, 2025, recommended Final Dividend of Rs. 3 per equity share.
Caplin Point Laboratories has announced a board meeting outcome declaring an interim dividend of ₹3.00 per share (150% on ₹2 face value). The record date for dividend eligibility is May 30, 2025. FY25 total revenue rose 15.5% YoY to ₹2,034 Cr, with PAT up 17.3% to ₹541 Cr. Strong cash...